{
    "Trade/Device Name(s)": [
        "AggreGuide A-100",
        "AggreGuide A-100 AA Assay"
    ],
    "Submitter Information": "Aggredyne, Inc.",
    "510(k) Number": "K122162",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042423"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JOZ"
    ],
    "Summary Letter Date": "December 20, 2013",
    "Summary Letter Received Date": "December 19, 2013",
    "Submission Date": "December 18, 2013",
    "Regulation Number(s)": [
        "21 CFR 864.5700"
    ],
    "Regulation Name(s)": [
        "Automated platelet aggregation system"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "Platelet aggregation",
        "Arachidonic acid-induced platelet activity"
    ],
    "Specimen Type(s)": [
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "3.2% sodium citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "AggreGuide A-100 instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Laser light scattering",
        "Disposable assay cartridge"
    ],
    "Methodologies": [
        "Platelet aggregation detection"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Assay",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for AggreGuide A-100 and AggreGuide A-100 AA Assay using laser light scattering to qualitatively detect platelet dysfunction due to aspirin ingestion.",
    "Indications for Use Summary": "Aids in the detection of platelet dysfunction due to aspirin ingestion for individuals 18 years or older using citrated venous whole blood and the AggreGuide A-100 instrument; for professional use and not for patients with congenital or non-aspirin acquired platelet abnormalities or those on non-aspirin antiplatelet agents.",
    "fda_folder": "Hematology"
}